Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 19/20 | 0.55 |
| ▸ | CNR1 | P21554 | 15/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5425933 | 0.92 | CNR2 (0.57) | CNR2CNR1TRPV1 | |
| SCHEMBL10653170 | 0.86 | CNR1 (0.61) | CNR2CNR1 | |
| SCHEMBL23802246 | 0.85 | CNR2 (0.50) | CNR2CNR1TRPV1 | |
| SCHEMBL10724501 | 0.85 | CNR2 (0.58) | CNR2CNR1TRPV1 | |
| SCHEMBL10914094 | 0.82 | CNR2 (0.53) | CNR2CNR1TRPV1 | |
| SCHEMBL23461339 | 0.81 | CNR2 (0.48) | CNR2CNR1TRPV1 | |
| SCHEMBL23461341 | 0.81 | CNR2 (0.48) | CNR2CNR1TRPV1 | |
| SCHEMBL9080244 | 0.80 | KDM4E (0.48) | CNR2CNR1TRPV1 | |
| SCHEMBL17129735 | 0.78 | ALDH1A1 (0.46) | CNR2CNR1TRPV1 | |
| SCHEMBL23461342 | 0.78 | CNR2 (0.52) | CNR2CNR1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198223-A1 | METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL | CORBUS PHARMACEUTICALS, INC. | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198223-A1 | METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL | CNR1, DHCR24, CNR2 | CNR2 3/4885CNR1 1/4885TRPV1 627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.